Swiss Re (VTX:SREN) received a CHF 107 price objective from research analysts at HSBC in a research note issued on Friday. The firm presently has a “buy” rating on the stock. HSBC’s price target indicates a potential upside of 13.20% from the stock’s previous close.
Several other equities analysts have also issued reports on the company. Barclays set a CHF 97.70 price target on Swiss Re and gave the stock a “buy” rating in a research report on Monday, December 11th. Goldman Sachs Group set a CHF 95 price target on Swiss Re and gave the stock a “neutral” rating in a research report on Thursday, December 7th. UBS Group set a CHF 79 price target on Swiss Re and gave the stock a “sell” rating in a research report on Tuesday, October 10th. JPMorgan Chase & Co. set a CHF 104 price target on Swiss Re and gave the stock a “buy” rating in a research report on Friday, October 20th. Finally, Deutsche Bank set a CHF 110 price target on Swiss Re and gave the stock a “buy” rating in a research report on Wednesday, October 25th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of CHF 96.84.
Swiss Re (VTX SREN) opened at CHF 94.52 on Friday. Swiss Re has a 1 year low of CHF 81.65 and a 1 year high of CHF 95.30. The stock has a market capitalization of $32,800.00 and a P/E ratio of 12.09.
Swiss Re Company Profile
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.